Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2007; 13(16): 2312-2318
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2312
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2312
Table 3 Study of the correlation between therapeutic modalities of CrD and detection of ASCA
Treatment of CrDpatients | Number of patients | Number of positivepatients for ASCA (%) | P |
Medical treatment | NS | ||
Corticosteroids | 27 | 15 (55) | |
Immunosuppressive | 19 | 8 (42) | |
Drugs (IS) | |||
Corticosteroids + IS | 18 | 10 (55) | |
Other treatment | 25 | 9 (36) | |
No treatment | 11 | 5 (45) | |
Surgical treatment | NS | ||
Presence | 21 | 11 (52) | |
Absence | 79 | 40 (51) |
-
Citation: Desplat-Jégo S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, Ballot E, Sarles J, Baudon J, Grimaud J, Veyrac M, Chamouard P, Humbel R. Update on Anti-
Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study. World J Gastroenterol 2007; 13(16): 2312-2318 - URL: https://www.wjgnet.com/1007-9327/full/v13/i16/2312.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i16.2312